Hedge Funds Bet Big On Johnson & Johnson (JNJ): Top Healthcare Stock to Watch

3 Dividend Stocks That Are Screaming Buys in November

2 Unstoppable Dividend Stocks to Buy Now With $500

2 Dow Jones Dividend Stocks With Yields Above 3% You Can Buy Now and Hold at Least a Decade

Sanofi Plans to Change Hospital Drug-Discount Program

J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis

Medtronic acquires Fortimedix Surgical to boost surgical portfolio

Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma

Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor

Johnson & Johnson (NYSE:JNJ) Stock Goes Ex-Dividend In Just Three Days

Health Canada Authorizes CARVYKTI® (ciltacabtagene autoleucel) for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy

Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China